Immunotherapy with Rituximab during Peripheral Blood Stem Cell Transplantation for Non-Hodgkin's Lymphoma

Biology of Blood and Marrow Transplantation

Volumn 6, Issue 6, 2000, Pages 628-632

  Flinn, Ian W ^a,b   O'Donnell, Paul V ^a   Goodrich, Amy ^a   Vogelsang, Georgia ^a   Abrams, Ross ^a   Noga, Steve ^a   Marcellus, Deborah ^a   Borowitz, Michael ^a   Jones, Richard ^a   Ambinder, Richard F ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Immunotherapy; Lymphoma; Rituximab; Transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; RITUXIMAB;

ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW PURGING; CLINICAL TRIAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NONHODGKIN LYMPHOMA; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BONE MARROW PURGING; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOTHERAPY; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0033657113     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-8791(00)70028-0     Document Type: Article

References (20)

1. Philip T, Guglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med. 1995;333:1540-1546.
2. Freedman AS, Gribben JG, Neuberg D, et al. High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood. 1996;88:2780-2786.
3. Bachier CR, Giles RE, Ellerson D, et al. Hematopoietic retroviral gene marking in patients with follicular non-Hodgkin's lymphoma. Leuk Lymphoma. 1999;32:279-288.
4. Gribben JG, Freedman AS, Neuberg D, et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med. 1991;325:1525-1533.
5. Reff M, Leonard J, Newman R, Hanna N, Anderson D. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20 [abstract]. Blood. 1994;83:435-445.
6. Nadler LM, Ritz J, Hardy R, Pesando JM, Schlossman SF, Stashenko P. A unique cell surface antigen identifying lymphoid malignancies of B cell origin. J Clin Invest. 1981;67:134-140.
7. Anderson KC, Bates MP, Slaughenhoupt BL, Pinkus GS, Schlossman SF, Nadler LM. Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood. 1984;63:1424-1433.
8. Maloney D, Smith B, Appelbaum FR. The antitumor effects of monoclonal anti-CD20 antibody (MAB) therapy includes direct anti-proliferative activity and induction of apoptosis in CD20 positive non-Hodgkin's lymphoma (NHL) cell lines [abstract]. Blood. 1996;88:637a.
9. Demidem A, Lam T, Alas S, Hariharan K, Hanna N, Bonavida B. Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs. Cancer Biother Radiopharm. 1997;12:177-186.
10. Czuczman M, Grillo-Lopez A, Maloney D. Rituximab clearance of bcl-2 positive cells from peripheral blood and bone marrow from patients with relapsed low-grade follicular lymphoma [abstract]. Proc Am Assoc Can Res. 1999;40:4748.
11. Jones RJ. Purging with 4-hydroperoxycyclophosphamide. J Hematother. 1992;1:343-348.
12. Abrams RA, Liu PJ, Ambinder RF, et al. Hodgkin and non-Hodgkin lymphoma: local-regional radiation therapy after bone marrow transplantation. Radiology. 1997;203:865-870.
13. Santos GW, Tutschka PJ, Brookmeyer R, et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med. 1983; 309:1347-1353.
14. Wagner JE, Santos GW, Noga SJ, et al. Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trial. Blood. 1990;75:1370-1377.
15. Lee MS, Chang KS, Cabanillas F, Freireich EJ, Trujillo JM, Stass SA. Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science. 1987;237:175-178.
16. Rimokh R, Berger F, Delsol G, et al. Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood. 1994;83:1871-1875.
17. Hale G, Swirsky D, Waldmann H, Chan LC. Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation. Br J Haematol. 1985;60:41-48.
18. + peripheral-blood stem-cell transplants for follicular lymphoma: a pilot study. J Clin Oncol. 1997; 15:2288-2295.
19. Seber A, Zahurak M, Noga SJ, Jones RJ, Goodman S, Vogelsang GB. Transient leukocyte slump: a common occurrence after allogeneic BMT [abstract]. Blood. 1995;86:102a.
20. + hematopoietic progenitors. Blood. 1998;91:2588-2600.